{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:05:40Z","timestamp":1788519940892,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904072"],"award-info":[{"award-number":["81904072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jinf.2020.11.027","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T20:02:16Z","timestamp":1606334536000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: A cohort study"],"prefix":"10.1016","volume":"82","author":[{"given":"Shenglei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingluan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7335","key":"10.1016\/j.jinf.2020.11.027_bib0001","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from burkitt's lymphoma","volume":"1","author":"EPSTEIN","year":"1964","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jinf.2020.11.027_bib0002","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein\u2013Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nature Reviews Cancer"},{"issue":"apr21 2","key":"10.1016\/j.jinf.2020.11.027_bib0003","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1136\/bmj.h1825","article-title":"Infectious mononucleosis","volume":"350","author":"Lennon","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jinf.2020.11.027_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pathol.2019.09.011","article-title":"Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach","volume":"52","author":"Hue","year":"2020","journal-title":"Pathology"},{"issue":"7","key":"10.1016\/j.jinf.2020.11.027_bib0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"New Eng J Med"},{"issue":"2","key":"10.1016\/j.jinf.2020.11.027_bib0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.jinf.2020.11.027_bib0007","first-page":"1","article-title":"Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting","author":"Cohen","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.jinf.2020.11.027_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biologicals.2016.04.010","article-title":"A collaborative study to establish the 1st WHO international standard for epstein-barr virus for nucleic acid amplification techniques","volume":"44","author":"Fryer","year":"2016","journal-title":"Biologicals"},{"issue":"7","key":"10.1016\/j.jinf.2020.11.027_bib0009","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/JCM.02308-06","article-title":"Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood","volume":"45","author":"Hakim","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jinf.2020.11.027_bib0010","first-page":"475","article-title":"The biology and clinical utility of EBV monitoring in blood","volume":"391","author":"Kanakry","year":"2015","journal-title":"Current Topics Microbiology Immunol."},{"issue":"4","key":"10.1016\/j.jinf.2020.11.027_bib0011","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jiac.2015.11.002","article-title":"Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein\u2013Barr virus disease","volume":"22","author":"Ito","year":"2016","journal-title":"J. Infect. Chemotherapy"},{"issue":"8","key":"10.1016\/j.jinf.2020.11.027_bib0012","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/infdis\/jiz315","article-title":"Viral DNA loads in various blood components of patients with epstein-barr virus-positive T-Cell\/natural killer cell lymphoproliferative diseases","volume":"220","author":"Kawada","year":"2019","journal-title":"J Infect Dis"},{"issue":"21","key":"10.1016\/j.jinf.2020.11.027_bib0013","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","article-title":"Plasma epstein-barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma","volume":"94","author":"Chan","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"16","key":"10.1016\/j.jinf.2020.11.027_bib0014","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jinf.2020.11.027_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.jinf.2020.11.027_bib0016","doi-asserted-by":"crossref","first-page":"e99857","DOI":"10.1371\/journal.pone.0099857","article-title":"Epstein-barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence","volume":"9","author":"Xiong","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.11.027_bib0017","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jinf.2020.11.027_bib0018","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/BOR.0000000000000289","article-title":"How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?","volume":"28","author":"Draborg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.jinf.2020.11.027_bib0019","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood","volume":"6","author":"Moon","year":"2004","journal-title":"Arthritis Research Therapy"},{"issue":"10","key":"10.1016\/j.jinf.2020.11.027_bib0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"10.1016\/j.jinf.2020.11.027_bib0021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jinf.2020.11.027_bib0022","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.jinf.2020.11.027_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002328","article-title":"Exhausted cytotoxic control of Epstein-Barr virus in human lupus","volume":"7","author":"Larsen","year":"2011","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.jinf.2020.11.027_bib0024","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/587671","article-title":"Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation","volume":"46","author":"Gotoh","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jinf.2020.11.027_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"3792","key":"10.1016\/j.jinf.2020.11.027_bib0026","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.157.3792.1064","article-title":"Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells","volume":"157","author":"Henle","year":"1967","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jinf.2020.11.027_bib0027","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jclinpath-2011-200523","article-title":"T\/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T\/NK-cell lymphoma","volume":"65","author":"Isobe","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.jinf.2020.11.027_bib0028","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jinf.2020.11.027_bib0029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jinf.2020.11.027_bib0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jinf.2020.11.027_bib0031","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3109\/10428194.2014.963577","article-title":"A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types","volume":"56","author":"Tsai","year":"2015","journal-title":"Leukemia lymphoma"},{"issue":"5","key":"10.1016\/j.jinf.2020.11.027_bib0032","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1600-6143.2008.02183.x","article-title":"EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial","volume":"8","author":"Tsai","year":"2008","journal-title":"American journal of transplantation"},{"issue":"16","key":"10.1016\/j.jinf.2020.11.027_bib0033","first-page":"3750","article-title":"Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic\/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy","volume":"117","author":"An","year":"2011","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.jinf.2020.11.027_bib0034","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma epstein-barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"New Eng J Med"},{"issue":"2","key":"10.1016\/j.jinf.2020.11.027_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1586\/eci.12.111","article-title":"Determining EBV load: current best practice and future requirements","volume":"9","author":"Ruf","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"10.1016\/j.jinf.2020.11.027_bib0036","first-page":"3254","article-title":"Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma","volume":"9","author":"To","year":"2003","journal-title":"Clinical Cancer Res"},{"issue":"6","key":"10.1016\/j.jinf.2020.11.027_bib0037","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3109\/10428191003746331","article-title":"Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas","volume":"51","author":"Machado","year":"2010","journal-title":"Leukemia Lymphoma"},{"issue":"2","key":"10.1016\/j.jinf.2020.11.027_bib0038","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cam4.2710","article-title":"High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi","volume":"9","author":"Montgomery","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jinf.2020.11.027_bib0039","series-title":"Head & Neck","article-title":"Effects of Epstein\u2010Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma","author":"Twu","year":"2020"},{"issue":"18","key":"10.1016\/j.jinf.2020.11.027_bib0040","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","article-title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","volume":"121","author":"Kanakry","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320307222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320307222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:31:21Z","timestamp":1759008681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320307222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0163445320307222"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.11.027","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}